| |
Latest 10 SEC filings (by transaction date) for ALRN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 2/24 | Apr 2/24 | Garner Charles | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Apr 2/24 | Apr 2/24 | Garner Charles | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 6/24 | Mar 5/24 | Windsor James Brian | Direct Ownership | Series X Non-Voting Convertible Preferred | M - Exercise or conversion exempt under rule 16b-3 | -2 | |
Mar 6/24 | Mar 5/24 | Windsor James Brian | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,000 | |
Apr 10/24 | Feb 28/24 | Von Rickenbach Josef H | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Apr 10/24 | Feb 28/24 | Ambros Reinhard J. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Mar 1/24 | Feb 28/24 | Ambros Reinhard J. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Mar 1/24 | Feb 28/24 | Von Rickenbach Josef H | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Dec 18/23 | Dec 15/23 | Windsor James Brian | Indirect Ownership | Common Stock | P - Open market or private purchase | 225 | $3.37 |
Nov 21/23 | Nov 20/23 | Windsor James Brian | Direct Ownership | Common Stock | P - Open market or private purchase | 5,076 | $1.97 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ALRN within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 10/24 | Feb 28/24 | Von Rickenbach Josef H | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Apr 10/24 | Feb 28/24 | Ambros Reinhard J. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Apr 2/24 | Apr 2/24 | Garner Charles | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Apr 2/24 | Apr 2/24 | Garner Charles | Direct Ownership | Stock Option (right to buy) | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Mar 6/24 | Mar 5/24 | Windsor James Brian | Direct Ownership | Series X Non-Voting Convertible Preferred | M - Exercise or conversion exempt under rule 16b-3 | -2 | |
Mar 6/24 | Mar 5/24 | Windsor James Brian | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 2,000 | |
Mar 1/24 | Feb 28/24 | Ambros Reinhard J. | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Mar 1/24 | Feb 28/24 | Von Rickenbach Josef H | Direct Ownership | Stock Option (right to buy) | A - Grant, award or other under Rule 16b-3(d) | 2,725 | |
Dec 18/23 | Dec 15/23 | Windsor James Brian | Indirect Ownership | Common Stock | P - Open market or private purchase | 225 | $3.37 |
Nov 21/23 | Nov 20/23 | Windsor James Brian | Direct Ownership | Common Stock | P - Open market or private purchase | 5,076 | $1.97 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |